Pear Therapeutics
Prescription digital therapeutics company.
Based in MA
AI Overview
With $510K in lobbying spend across 16 quarterly filings, Pear Therapeutics is an active lobbying client. Their lobbying covers 3 issue areas. Active from 2019 to 2023.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2019 | $30K |
| 2020 | $160K |
| 2021 | $160K |
| 2022 | $150K |
| 2023 | $10K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Pear Therapeutics disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Medicare/Medicaid, Budget/Appropriations
Increase awareness of clinical use of FDA cleared prescription digital therapeutics and Medicare coverage.
H.R. 5333, Ensuring Patient Access to Critical Breakthrough Products Act of 2019, as it relates to Medicare coverage.
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.